Literature DB >> 9702157

1996 congressional campaign priorities of the AMA: tackling tobacco or limiting malpractice awards?

J Sharfstein1.   

Abstract

OBJECTIVES: This study sought to determine whether the political action committee of the American Medical Association (AMA) contributed more to pro- or anti-tobacco members of Congress in the 1995/96 campaign and whether representatives' voting records on malpractice reform could explain the AMA's contribution patterns.
METHODS: Campaign contributions to House members were analyzed.
RESULTS: The AMA's political action committee contributed averages of $5382 to pro-tobacco representatives and $2103 to anti-tobacco representatives (P < .0005). This contribution pattern can be fully explained by representatives' votes to limit malpractice awards.
CONCLUSIONS: In seeking malpractice reform, the AMA contributed significantly more to pro-tobacco representatives, potentially undermining tobacco control legislation.

Entities:  

Mesh:

Year:  1998        PMID: 9702157      PMCID: PMC1508293          DOI: 10.2105/ajph.88.8.1233

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  5 in total

1.  Dealing with tobacco--the implications of a legislative settlement with the tobacco industry.

Authors:  K E Warner
Journal:  Am J Public Health       Date:  1997-06       Impact factor: 9.308

2.  Contributions from the American Medical Political Action Committee to members of Congress.

Authors:  L R Bristow
Journal:  N Engl J Med       Date:  1994-06-02       Impact factor: 91.245

3.  Tobacco, history, and the AMA.

Authors:  L R Bristow
Journal:  Lancet       Date:  1995-09-09       Impact factor: 79.321

4.  Campaign contributions from the American Medical Political Action Committee to Members of Congress. For or against the public health?

Authors:  J M Sharfstein; S S Sharfstein
Journal:  N Engl J Med       Date:  1994-01-06       Impact factor: 91.245

5.  Epidemiology of failed tobacco control legislation.

Authors:  S Moore; S M Wolfe; D Lindes; C E Douglas
Journal:  JAMA       Date:  1994-10-19       Impact factor: 56.272

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.